Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ENFERMEDAD GRUPO REGISTRY PROYECTOS ENTRAR
 
 
  
Clinical Characteristics-cognitive -
--->Novedades
[-]El proyecto
--->Sponsor
--->[-]Comité Ejecutivo
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Documentos públicos
--->[+]Writing Committee Strategic ...
--->[+]Comité Científico y Bioético
--->Coordinador central
--->Coordinadores locales
--->Fellowship Programme
--->[+]Constitución
--->[-]Elecciones
--->[-]Miembros
--->Solicitud
[+]Centros
[-]Grupos de trabajo
--->[+]EH avanzada
--->[+]Fenotipo conductual
--->[+]Modificadores Biológicos
--->[+]Biomarcadores
--->[+]Banco de tejidos y cerebros...
--->[+]Fenotipo cognitivo
--->[+]Modificadores ambientales
--->[+]Evaluación Funcional
--->[+]Test y Consejo genético
--->[+]Genes Modificadores
--->[+]Economia de Salud
--->[+]Pruebas de imagen
--->[+]Huntington Juvenil
--->[+]Fenotipo motor
--->[+]Tratamiento Neuroprotector...
--->[+]Fisioterapia
--->[+]Calidad de vida
--->[+]Cuidados del paciente
--->[+]Tratamiento quirúrgico
--->[+]Tratamiento Sintomático
--->[+]Jóvenes
[-]Eventos
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Programa
--->Cena oficial
--->Inscripción
--->Grupos de Trabajo
--->Localización
--->Manchester
--->Valoración y Feedback
--->[+]EHDN 2004
[-]Comunicación
--->¿Cómo contactar?
--->Forums
--->Listas de correos
--->Publicación
--->Ofertas de trabajo
fechadescripcióntamañoautor documento 
03.08.26A comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in early stages of Huntington’s disease32 kBanonymousapplication/mswordj06-comparison--mmse-montreal-cognitiv... 
03.08.26Increased cognitive functioning in manifest HD - empirical evidence and computational modelling32 kBanonymousapplication/mswordj07-increased-cognitive-functioning 
03.08.26Cognitive Functions of the Putamen in Huntington’s Disease32 kBanonymousapplication/mswordj09-cognitive-functions-putamen 
03.08.26Development and characterization of the cognitive assessment battery (CAB-HD) for Huntington’s Disease clinical trials32 kBanonymousapplication/mswordj05-cab-hd 
03.08.26Measuring cognitive decline in Huntington’s Disease: a longitudinal analysis of the UHDRS cognitive battery32 kBanonymousapplication/mswordj04-cognitive-decline-in-hd 
03.08.26What are the best cognitive tests for clinical trials?: the devil is in the details32 kBanonymousapplication/mswordj02-best-cognitive-tests-clinical-trials 
03.08.26The potential of a composite cognitive score for tracking progression in Huntington's Disease32 kBanonymousapplication/mswordj03-cognitive-score-tracking-progression 
03.08.26Neuropathology of the ventral striatum and extended amygdala in Huntingon Disease32 kBanonymousapplication/mswordj10-neuropathology-ventral-striatum-ex... 
03.08.26Altered reward processing in pre-symptomatic carriers of the Huntington gene – hypercompensation as a potential mechanism32 kBanonymousapplication/mswordj11-hypercompensation-potential-mechan... 
03.08.26Multitasking processes are sensitive to early changes in pre-HD - evidence from longitudinal neurophysiological data32 kBanonymousapplication/mswordj16-multitasking-processes-are-sensitive 
03.08.26Apathy prevalence and clinical correlations in Huntington’s Disease32 kBanonymousapplication/mswordj17-apathy-prevalence-and-clinical-cor... 
03.08.26Dual task performance in Huntington’s Disease: comparing choice reaction time tasks32 kBanonymousapplication/mswordj15-comparing-choice-reaction-time-tasks 
03.08.26Cognitive and emotional contributions to quality of life in Huntington’s Disease32 kBanonymousapplication/mswordj14-cognitive-and-emotional-contributi... 
03.08.26Affective pictures perception in early Huntington's Disease: valence, arousal and brain responses32 kBanonymousapplication/mswordj12-valence--arousal-and-brain-responses 
03.08.26Distributed neural networks associated with emotion processing are altered in premanifest Huntington’s Disease and correlated with genetic load32 kBanonymousapplication/mswordj13-distributed-neural-networks 
03.08.26Cortisol levels are associated with verbal memory performance in the early stages of Huntington’s disease32 kBanonymousapplication/mswordj0x-cortisol-levels-verbal-memory 

Esta carpeta contiene 16 documentos.
about us | privacy statement | disclaimer | terms of use